Quetiapine Fumarate XR Tablets
SPE2D223R0010
The Defense Logistics Agency plans a national requirements contract for Quetiapine Fumarate XR Tablets in five specified strengths. The firm-fixed price contract will have a one-year base period and four one-year option periods. It will establish a national supply source for several federal agencies through their prime vendor programs. The solicitation is projected for March 2023, though this date is subject to change. The acquisition is unrestricted, fully competitive, and for a commercial item.